[HTML][HTML] The analysis of pharmacokinetic and pharmacogenomic impact on gefitinib efficacy in advanced non-small cell lung cancer patients: results from a …
Y Ma, S Xin, Q Lin, W Zhuang, Y Zhao… - Annals of …, 2019 - ncbi.nlm.nih.gov
Background The current study is aimed to examine the impact of pharmacokinetics and
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
[PDF][PDF] The analysis of pharmacokinetic and pharmacogenomic impact on gefitinib efficacy in advanced non-small cell lung cancer patients: results from a prospective …
Y Ma, S Xin, Q Lin, W Zhuang, Y Zhao, X Zhu, H Zhao… - 2019 - cdn.amegroups.cn
Background: The current study is aimed to examine the impact of pharmacokinetics and
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
[PDF][PDF] The analysis of pharmacokinetic and pharmacogenomic impact on gefitinib efficacy in advanced non-small cell lung cancer patients: results from a prospective …
Y Ma, S Xin, Q Lin, W Zhuang, Y Zhao, X Zhu, H Zhao… - 2019 - pdfs.semanticscholar.org
Background: The current study is aimed to examine the impact of pharmacokinetics and
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
The analysis of pharmacokinetic and pharmacogenomic impact on gefitinib efficacy in advanced non-small cell lung cancer patients: results from a prospective cohort …
Y Ma, S Xin, Q Lin, W Zhuang… - Annals of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background The current study is aimed to examine the impact of pharmacokinetics and
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
The analysis of pharmacokinetic and pharmacogenomic impact on gefitinib efficacy in advanced non-small cell lung cancer patients: results from a prospective cohort …
Y Ma, S Xin, Q Lin, W Zhuang, Y Zhao… - Annals of …, 2019 - europepmc.org
Background The current study is aimed to examine the impact of pharmacokinetics and
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
[HTML][HTML] The analysis of pharmacokinetic and pharmacogenomic impact on gefitinib efficacy in advanced non-small cell lung cancer patients: results from a …
Y Ma, S Xin, Q Lin, W Zhuang, Y Zhao… - Annals of …, 2019 - atm.amegroups.org
Background: The current study is aimed to examine the impact of pharmacokinetics and
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
[HTML][HTML] The analysis of pharmacokinetic and pharmacogenomic impact on gefitinib efficacy in advanced non-small cell lung cancer patients: results from a …
Y Ma, S Xin, Q Lin, W Zhuang, Y Zhao, X Zhu, H Zhao… - pillintrip.com
Background The current study is aimed to examine the impact of pharmacokinetics and
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
The analysis of pharmacokinetic and pharmacogenomic impact on gefitinib efficacy in advanced non-small cell lung cancer patients: results from a prospective cohort …
Y Ma, S Xin, Q Lin, W Zhuang, Y Zhao… - Annals of …, 2019 - atm.amegroups.org
Background: The current study is aimed to examine the impact of pharmacokinetics and
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …
gene polymorphisms of enzymes involving in absorption, distribution, metabolism and …